Search Results 1-10 of 16328 for Huntington%26%2339%3Bs%2Bdisease
This rare disease causes an early decay of nerve cells in the brain. Learn about its symptoms and how treatments may help.
This study is a 26 week, randomized, parallel group, double blind comparison of PF-02545920 5 mg, PF-02545920 20 mg, and placebo dosed BID in the treatment of ...
Primary endpoint is the change from baseline in the Total Motor Score (TMS) assessment of the Unified Huntington Disease Rating Scale (UHDRS) after 26 weeks of ...
Diagnosis · Neurological exam · Neuropsychological testing · Mental health evaluation · Brain-imaging and function tests · Genetic counseling and testing · Predictive ...
Experts in Mayo Clinic's Department of Clinical Genomics provide access to the latest genetic testing techniques, when medically appropriate. Mayo researchers ...
A Study to Investigate the Long Term Safety, Tolerability And Effectiveness of Pf-02545920 in Subjects with Huntington's Disease Who Completed Study A8241021.
About this study. The purpose of the study is to collect representative clinical images (head and whole-body scans) of demonstrated diagnostic quality using ...
The purpose of this study is to evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics of tocilizumab (TCZ) compared with a matching placebo ...
Mayo Clinic Laboratories.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.